image
Syndax Pharmaceuticals, Inc. SNDX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 12.92
3.38 %
$ 1.11 B
Market Cap
-3.21
P/E
BALANCE SHEET
725 M ASSETS
18.26%
Growth Rates
1Year 18.26%
3Years 17.25%
5Years 62.73%
7Years 26.85%
10Years 49.71%
437 M LIABILITIES
644.14%
Growth Rates
1Year 644.14%
3Years 119.51%
5Years 68.74%
7Years 44.71%
10Years 37.16%
288 M EQUITY
-48.01%
Growth Rates
1Year -48.01%
3Years -10.98%
5Years 55.59%
7Years 15.62%
10Years 48.57%
BALANCE SHEET DECOMPOSITION
Balance Sheet Syndax Pharmaceuticals, Inc.
image
Current Assets 603 M
Cash & Short-Term Investments 573 M
Receivables 11.2 M
Other Current Assets 18.9 M
Non-Current Assets 122 M
Long-Term Investments 120 M
PP&E 2.02 M
Other Non-Current Assets 217 K
79.04 %16.49 %Total Assets$724.8m
Current Liabilities 104 M
Accounts Payable 11.6 M
Short-Term Debt 12.6 M
Other Current Liabilities 79.3 M
Non-Current Liabilities 230 M
Long-Term Debt 1.58 M
Other Non-Current Liabilities 228 M
3.49 %3.78 %23.81 %68.44 %Total Liabilities$333.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 154.1 295.4 74.4 222.0 115.2 24.6 33.8 35.2 23.8 23.2 10.0 10.1 0.5 3.7
Short Term Investments 418.8 282.2 410.0 218.0 177.8 35.2 47.1 94.8 81.5 64.1 2.2 4.2 91 K 0.6
Receivables 11.2 1.2 4.1 0.4 0.2 0.1 0.3 0.4 0.3 0.3 35 K 0 0 0
Inventory 0.4 0 (4.3) 7.7 5.3 1.7 1.1 (1.4) 2.4 0.3 51 K 0 0 0
Other Current Assets 18.6 2.1 9.9 7.9 5.6 2.4 2.1 3.0 2.9 1.2 0.1 0.3 0.1 77 K
Total Current Assets 603.1 580.9 481.3 448.4 298.9 62.3 83.3 133.4 108.5 88.0 12.4 14.5 0.7 4.4
PP&E 2.0 1.5 1.1 1.3 0.5 1.0 0.4 0.3 0.3 88 K 33 K 40 K 20 K 50 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 119.5 29.8 5.5 0 0.1 0.1 0 3.2 0 0 0 0 0 0
Other Long Term Assets 0.2 0.7 9.4 0 1.2 82 K 0.2 0.2 0.2 1.8 0.3 2.5 0.8 0.3
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 1
Total Assets 724.8 612.9 497.2 449.7 300.6 63.5 83.9 137.2 109.0 89.9 12.8 17.1 1.5 4.8
LIABILITIES
Accounts Payable 11.6 10.0 4.3 5.7 3.5 6.2 1.4 2.2 2.4 1.5 0.4 1.1 0.8 0.8
Short Term Debt 12.6 1.0 0.4 0.4 2.6 0.5 0 0 0 0 6.4 0 21.3 10.7
Other Current Liabilities 79.3 47.1 24.3 14.7 11.2 10.2 13.1 12.0 6.8 2.2 3.5 1.7 3.0 1.9
Total Current Liabilities 103.5 58.1 29.1 20.7 18.9 18.4 16.1 15.8 10.4 4.8 10.3 2.7 25.1 13.4
Long Term Debt 1.6 0.6 0.7 20.6 17.9 0.4 0 0 0 0 7.4 0 0 8.7
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 228.0 0 0 0 1 K 5 K 0.1 0.3 0.3 2.9 0.8 2.5 5.7 1.8
Total Liabilities 436.7 58.7 29.8 41.3 48.4 31.9 30.9 32.9 24.9 23.2 18.5 5.2 30.8 23.8
EQUITY
Common Stock 9 K 8 K 7 K 6 K 5 K 3 K 2 K 2 K 2 K 1 K 1 K 1 K 0 0
Retained Earnings (1 221.2) (902.4) (693.0) (543.7) (568.6) (495.5) (439.4) (366.1) (305.3) (259.7) (159.8) (135.7) (79.1) (68.9)
Other Accumulative Comprehensive Income/Loss 0.2 0.2 (0.8) 45 K 4 K 0 25 K (0.1) 56 K 28 K (0.2) (0.2) (0.2) 0
Total Equity 288.1 554.2 467.4 408.4 252.2 31.6 53.0 104.3 84.1 66.7 (5.7) 11.8 (29.3) (19.1)
Total Liabilities and Equity 724.8 612.9 497.2 449.7 300.6 63.5 83.9 137.2 109.0 89.9 12.8 17.1 1.5 4.8
SHARES OUTSTANDING
Common Shares Outstanding 85.4 70.3 60.8 52.1 41.3 30.5 25.4 21.0 14.6 17.4 9.6 8.0 70.3 0.6